Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...
Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
Clarify Health’s Acquisition of Embedded Healthcare
Latham & Watkins represented Clarify Health in the transaction. Clarify Health, a leading cloud analytics and value-based payments platform company, has announced the acquisition of Embedded...
CooperCompanies’ Acquisition of Cook Medical’s Reproductive Health Business
Latham & Watkins represented CooperCompanies in the transaction. CooperCompanies has announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer...
Patient Square Capital’s Acquisition of SOC Telemed
Orrick, Herrington & Sutcliffe acted as deal legal counsel to SOC Telemed and DLA Piper acted as healthcare legal counsel to SOC Telemed. Kirkland & Ellis...
Coherus BioSciences’ $300 Million Credit Financing with Pharmakon Advisors
Latham & Watkins represented Coherus in the transaction. Coherus BioSciences, Inc. (Coherus or the Company) (Nasdaq: CHRS) has entered into a loan agreement with investment funds managed...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
Medtronic’s Acquisition of Affera
Latham & Watkins represented Affer in the transaction. Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has announced that it has entered into a definitive agreement...
Royal Philips’ Acquisition of Vesper Medial
Latham & Watkins represented Vesper Medical in the transaction. Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, has signed an agreement to...
Oracle’s $28.3 Billion Acquisition of Cerner
Latham & Watkins represented Cerner in the transaction. Hogan Lovells advised Oracle Corporation. Fried Frank acted as counsel to Goldman Sachs and Centerview Partners as financial...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...